UPDATE: Piper Jaffray Upgrades Forest Laboratories, Previous Thesis is No Longer Tenable
November 26, 2013 at 10:57 AM EST
In a report published Tuesday, Piper Jaffray analyst David Amsellem upgraded the rating on Forest Laboratories (NYSE: FRX ) from Underweight to Neutral, and raised the price target from $33.00 to $49.00. In the report, Piper Jaffray noted, “We are upgrading Forest to a Neutral from an Underweight and raising
